AMC6156

· Animuscure Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMC6156, covering 2025-07-29 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AMC6156 in People With Sarcopenia [Phase 2]